PZ Cormay SA (CRM) - Net Assets

Latest as of March 2026: zł44.52 Million PLN ≈ $12.25 Million USD

Based on the latest financial reports, PZ Cormay SA (CRM) has net assets worth zł44.52 Million PLN (≈ $12.25 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (zł87.98 Million ≈ $24.21 Million USD) and total liabilities (zł43.46 Million ≈ $11.96 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check asset allocation strategy of PZ Cormay SA to assess the company's strategic physical and investment asset allocation.

Key Net Assets Metrics

Metric Value
Current Net Assets zł44.52 Million
% of Total Assets 50.6%
Annual Growth Rate 5.49%
5-Year Change -28.41%
10-Year Change -67.52%
Growth Volatility 41.82

PZ Cormay SA - Net Assets Trend (2008–2025)

This chart illustrates how PZ Cormay SA's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see CRM market cap overview.

Annual Net Assets for PZ Cormay SA (2008–2025)

The table below shows the annual net assets of PZ Cormay SA from 2008 to 2025. Also explore CRM net assets growth trend to track the company's year-over-year net asset growth rate.

Year Net Assets Change
2025-12-31 zł47.04 Million
≈ $12.95 Million
-5.92%
2024-12-31 zł50.00 Million
≈ $13.76 Million
-10.18%
2023-12-31 zł55.67 Million
≈ $15.32 Million
-9.86%
2022-12-31 zł61.76 Million
≈ $17.00 Million
-6.01%
2021-12-31 zł65.70 Million
≈ $18.08 Million
+3.77%
2020-12-31 zł63.32 Million
≈ $17.43 Million
-14.23%
2019-12-31 zł73.82 Million
≈ $20.32 Million
-37.81%
2018-12-31 zł118.70 Million
≈ $32.67 Million
-12.52%
2017-12-31 zł135.68 Million
≈ $37.34 Million
-6.31%
2016-12-31 zł144.82 Million
≈ $39.86 Million
-16.84%
2015-12-31 zł174.15 Million
≈ $47.93 Million
-6.74%
2014-12-31 zł186.73 Million
≈ $51.39 Million
-18.10%
2013-12-31 zł227.99 Million
≈ $62.75 Million
+18.46%
2012-12-31 zł192.46 Million
≈ $52.97 Million
+79.26%
2011-12-31 zł107.36 Million
≈ $29.55 Million
+61.57%
2010-12-31 zł66.45 Million
≈ $18.29 Million
+55.23%
2009-12-31 zł42.81 Million
≈ $11.78 Million
+125.84%
2008-12-31 zł18.95 Million
≈ $5.22 Million
--

Equity Component Analysis

This analysis shows how different components contribute to PZ Cormay SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 2600.1% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Common Stock zł84.20 Million 183.34%
Other Comprehensive Income zł6.47 Million 14.09%
Other Components zł92.81 Million 202.07%
Total Equity zł45.93 Million 100.00%

PZ Cormay SA Competitors by Market Cap

The table below lists competitors of PZ Cormay SA ranked by their market capitalization.

Company Market Cap
Gaya Abadi Sempurna 
JK:SLIS
$12.70 Million
Supermarket Income REIT PLC
LSE:SUPR
$12.71 Million
Regentis Biomaterials Ltd.
NYSE:RGNT
$12.71 Million
Sarytogan Graphite Ltd
AU:SGA
$12.72 Million
Swissnet AG
F:81D
$12.70 Million
CANADIAN NORTH RESOURCES
F:EO0
$12.70 Million
Park Ha Biological Technology Co., Ltd.
NASDAQ:BYAH
$12.69 Million
NSN Co. Ltd
KQ:031860
$12.68 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in PZ Cormay SA's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 49,560,000 to 45,929,000, a change of -3,631,000 (-7.3%).
  • Net loss of 4,162,000 reduced equity.
  • Other comprehensive income increased equity by 532,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income zł-4.16 Million -9.06%
Other Comprehensive Income zł532.00K +1.16%
Other Changes zł-1.00K -0.0%
Total Change zł- -7.33%

Book Value vs Market Value Analysis

This analysis compares PZ Cormay SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.00x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has increased from 0.38x to 1.00x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2008-12-31 zł1.45 zł0.55 x
2009-12-31 zł1.78 zł0.55 x
2010-12-31 zł2.47 zł0.55 x
2011-12-31 zł3.30 zł0.55 x
2012-12-31 zł4.93 zł0.55 x
2013-12-31 zł3.67 zł0.55 x
2014-12-31 zł2.48 zł0.55 x
2015-12-31 zł2.16 zł0.55 x
2016-12-31 zł1.60 zł0.55 x
2017-12-31 zł1.97 zł0.55 x
2018-12-31 zł1.43 zł0.55 x
2019-12-31 zł0.86 zł0.55 x
2020-12-31 zł0.74 zł0.55 x
2021-12-31 zł0.77 zł0.55 x
2022-12-31 zł0.73 zł0.55 x
2023-12-31 zł0.61 zł0.55 x
2024-12-31 zł0.59 zł0.55 x
2025-12-31 zł0.55 zł0.55 x

Capital Efficiency Dashboard

This dashboard shows how efficiently PZ Cormay SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -9.06%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -4.32%
  • • Asset Turnover: 1.09x
  • • Equity Multiplier: 1.92x
  • Recent ROE (-9.06%) is below the historical average (-8.40%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2008 7.49% 4.57% 1.12x 1.47x zł-475.30K
2009 6.91% 7.69% 0.76x 1.19x zł-1.32 Million
2010 9.23% 9.90% 0.73x 1.28x zł-514.80K
2011 12.95% 15.56% 0.56x 1.48x zł3.19 Million
2012 8.92% 14.58% 0.43x 1.44x zł-1.87 Million
2013 4.00% 6.80% 0.34x 1.73x zł-10.28 Million
2014 -48.13% -47.30% 0.39x 2.58x zł-57.20 Million
2015 -4.09% -11.46% 0.20x 1.80x zł-17.75 Million
2016 -10.77% -13.36% 0.44x 1.84x zł-21.19 Million
2017 -1.57% -2.60% 0.44x 1.35x zł-14.91 Million
2018 -22.36% -35.79% 0.43x 1.45x zł-36.16 Million
2019 -56.78% -59.89% 0.67x 1.42x zł-48.19 Million
2020 -20.28% -19.40% 0.70x 1.50x zł-18.91 Million
2021 2.52% 1.93% 0.85x 1.54x zł-4.85 Million
2022 -11.37% -8.16% 0.84x 1.66x zł-13.09 Million
2023 -8.21% -5.51% 0.88x 1.70x zł-10.06 Million
2024 -10.63% -5.75% 1.02x 1.81x zł-10.22 Million
2025 -9.06% -4.32% 1.09x 1.92x zł-8.75 Million

Industry Comparison

This section compares PZ Cormay SA's net assets metrics with peer companies in the Scientific & Technical Instruments industry.

Industry Context

  • Industry: Scientific & Technical Instruments
  • Average net assets among peers: $90,859,228
  • Average return on equity (ROE) among peers: 1559.21%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
PZ Cormay SA (CRM) zł44.52 Million 7.49% 0.98x $12.70 Million
Aplisens SA (APN) $214.57 Million 14.73% 0.08x $59.09 Million
Introl S.A. (INL) $99.78 Million 14.88% 0.37x $59.85 Million
Sonel S.A. (SON) $60.17 Million 7720.53% 0.14x $50.09 Million
Satis Group S.A. (STS) $74.72 Million 33.56% 1.01x $753.16K
Neptis (YAN) $5.06 Million 12.32% 1.89x $41.28 Million

About PZ Cormay SA

WAR:CRM Poland Scientific & Technical Instruments
Market Cap
$12.70 Million
zł46.14 Million PLN
Market Cap Rank
#26538 Global
#280 in Poland
Share Price
zł0.55
Change (1 day)
+0.00%
52-Week Range
zł0.35 - zł0.79
All Time High
zł3.52
About

PZ Cormay S.A., a diagnostic company, provides IVD solutions in Poland and internationally. The company offers analyzers, reagents, cleaning liquids, calibrators, control materials, patterns, and agglutination tests. It also provides analyzers, test strips, inspections, and calibration strips. In addition, the company offers parasitology, such as Paragreen Mini-System, a specialized device for co… Read more